We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. Sees Pluses in EU System as It Considers Device Review Redesign
U.S. Sees Pluses in EU System as It Considers Device Review Redesign
January 5, 2012
For some devices, laboratory testing and computer modeling may offer better product review data than clinical trials, a U.S. Food and Drug Administration (FDA) official said.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor